April 24, 2013 – Dr. McAllister presented Cytograft's clinical progress at the American Heart Association's Emerging Science Series "Innovations in Vascular Bioengineering"
      • Webinar recording available HERE.
April 17, 2013 - Dr. L’Heureux presented a webinar for young professionals on "Developing an Industry Career in Biomedical Engineering". More information available via BMES.
April 10, 2013 – Society for Biomaterials 2013 Annual Meeting- Adam Young presented on work creating dermal fillers using Cytograft's TESA technology.
December 8, 2012 - Dr. L’Heureux was invited to Tianjin to speak at the International Symposium on Small Diameter Vascular Grafts.
April 23, 2012 – Dr. L’Heureux reports a new process with cell synthesized threads at the annual FASEB meeting.
      • Press release can be found HERE.
      • Scientific American story HERE.
      • MIT Technology Review HERE.

Our Company

Cytograft is an established leader in the field of Cardiovascular Regenerative Medicine. Using cells harvested from the patient or another human donor, we are able to repair diseased cardiovascular tissues and organs.

Vision Statement

Cytograft's vision is to revolutionize cardiovascular medicine by developing cell-based therapies to repair and rebuild diseased tissues and organs without using synthetic biomaterials.

Mission Statement

Cytograft's mission is to dramatically improve cardiovascular medicine by bringing clinically useful and cost effective cell-based therapies to patients.